660 related articles for article (PubMed ID: 30498202)
1. Non-invasive delivery strategies for biologics.
Anselmo AC; Gokarn Y; Mitragotri S
Nat Rev Drug Discov; 2019 Jan; 18(1):19-40. PubMed ID: 30498202
[TBL] [Abstract][Full Text] [Related]
2. Strategies for non-invasive delivery of biologics.
Chung SW; Hil-lal TA; Byun Y
J Drug Target; 2012 Jul; 20(6):481-501. PubMed ID: 22632037
[TBL] [Abstract][Full Text] [Related]
3. Challenges and Future Prospects for the Delivery of Biologics: Oral Mucosal, Pulmonary, and Transdermal Routes.
Morales JO; Fathe KR; Brunaugh A; Ferrati S; Li S; Montenegro-Nicolini M; Mousavikhamene Z; McConville JT; Prausnitz MR; Smyth HDC
AAPS J; 2017 May; 19(3):652-668. PubMed ID: 28194704
[TBL] [Abstract][Full Text] [Related]
4. Oral inhalation for delivery of proteins and peptides to the lungs.
Fröhlich E; Salar-Behzadi S
Eur J Pharm Biopharm; 2021 Jun; 163():198-211. PubMed ID: 33852968
[TBL] [Abstract][Full Text] [Related]
5. Nanocarriers for oral delivery of biologics: small carriers for big payloads.
Cao Y; Rewatkar P; Wang R; Hasnain SZ; Popat A; Kumeria T
Trends Pharmacol Sci; 2021 Nov; 42(11):957-972. PubMed ID: 34593258
[TBL] [Abstract][Full Text] [Related]
6. Overview and Future Potential of Buccal Mucoadhesive Films as Drug Delivery Systems for Biologics.
Montenegro-Nicolini M; Morales JO
AAPS PharmSciTech; 2017 Jan; 18(1):3-14. PubMed ID: 27084567
[TBL] [Abstract][Full Text] [Related]
7. Current challenges in non-invasive insulin delivery systems: a comparative review.
Khafagy el-S; Morishita M; Onuki Y; Takayama K
Adv Drug Deliv Rev; 2007 Dec; 59(15):1521-46. PubMed ID: 17881081
[TBL] [Abstract][Full Text] [Related]
8. Advanced formulations for intranasal delivery of biologics.
Rohrer J; Lupo N; Bernkop-Schnürch A
Int J Pharm; 2018 Dec; 553(1-2):8-20. PubMed ID: 30316796
[TBL] [Abstract][Full Text] [Related]
9. Alternative routes of insulin delivery.
Owens DR; Zinman B; Bolli G
Diabet Med; 2003 Nov; 20(11):886-98. PubMed ID: 14632713
[TBL] [Abstract][Full Text] [Related]
10. Oral Delivery of Biologics for Precision Medicine.
Durán-Lobato M; Niu Z; Alonso MJ
Adv Mater; 2020 Apr; 32(13):e1901935. PubMed ID: 31222910
[TBL] [Abstract][Full Text] [Related]
11. Inhaled Biologics: From Preclinical to Product Approval.
Fathe K; Ferrati S; Moraga-Espinoza D; Yazdi A; Smyth HD
Curr Pharm Des; 2016; 22(17):2501-21. PubMed ID: 26861725
[TBL] [Abstract][Full Text] [Related]
12. Novel non-invasive protein and peptide drug delivery approaches.
Wallis L; Kleynhans E; Toit TD; Gouws C; Steyn D; Steenekamp J; Viljoen J; Hamman J
Protein Pept Lett; 2014; 21(11):1087-101. PubMed ID: 25106909
[TBL] [Abstract][Full Text] [Related]
13. Dosing considerations for inhaled biologics.
Ferrati S; Wu T; Kanapuram SR; Smyth HDC
Int J Pharm; 2018 Oct; 549(1-2):58-66. PubMed ID: 30053488
[TBL] [Abstract][Full Text] [Related]
14. Progress in nanoparticulate systems for peptide, proteins and nucleic acid drug delivery.
Slomkowski S; Gosecki M
Curr Pharm Biotechnol; 2011 Nov; 12(11):1823-39. PubMed ID: 21902630
[TBL] [Abstract][Full Text] [Related]
15. Current advances in delivery of biotherapeutics across the blood-brain barrier.
Rajadhyaksha M; Boyden T; Liras J; El-Kattan A; Brodfuehrer J
Curr Drug Discov Technol; 2011 Jun; 8(2):87-101. PubMed ID: 21513485
[TBL] [Abstract][Full Text] [Related]
16. Particle engineering principles and technologies for pharmaceutical biologics.
Cun D; Zhang C; Bera H; Yang M
Adv Drug Deliv Rev; 2021 Jul; 174():140-167. PubMed ID: 33845039
[TBL] [Abstract][Full Text] [Related]
17. Understanding molecular mechanisms of biologics drug delivery and stability from NMR spectroscopy.
Phyo P; Zhao X; Templeton AC; Xu W; Cheung JK; Su Y
Adv Drug Deliv Rev; 2021 Jul; 174():1-29. PubMed ID: 33609600
[TBL] [Abstract][Full Text] [Related]
18. Carrier Mediated Systemic Delivery of Protein and Peptide Therapeutics.
Zaman R; Othman I; Chowdhury EH
Curr Pharm Des; 2016; 22(40):6167-6191. PubMed ID: 27510479
[TBL] [Abstract][Full Text] [Related]
19. How to overcome the limitations of current insulin administration with new non-invasive delivery systems.
Sousa F; Castro P; Fonte P; Sarmento B
Ther Deliv; 2015 Jan; 6(1):83-94. PubMed ID: 25565442
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous Delivery of High-Dose/Volume Biologics: Current Status and Prospect for Future Advancements.
Badkar AV; Gandhi RB; Davis SP; LaBarre MJ
Drug Des Devel Ther; 2021; 15():159-170. PubMed ID: 33469268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
